longbridge

Ultragenyx Pharma

RARE
14.8902.68% ( -0.410 )
Trading: Oct 13, 13:37:30 (EDT)

All Shareholders

Shareholder Type

  • Institutions84.19%
  • Hedge funds12.68%
  • Individuals & Insiders3.13%
  • Private companies<0.01%
  • State-owned enterprises0.00%

Major Shareholders

Major Shareholders Latest
Shareholder
BlackRock, Inc.
10.84%10.65M3.40%+3.35M
RTW Investments, LP
7.93%7.80M4.21%+4.15M
Vanguard Portfolio Management, LLC
6.91%6.79M1.42%+1.40M
AQR Capital Management, LLC
6.65%6.53M2.00%+1.97M
State Street Investment Management
6.27%6.16M1.15%+1.14M
Vanguard Capital Management, LLC
5.05%4.97M0.16%+169.85K
Two Sigma Investments, LP
3.68%3.62M1.44%+1.42M
Sands Capital Management, LLC
3.21%3.16M0.06%-56.17K
Jacobs Levy Equity Management Inc
2.99%2.94M1.53%+1.51M
Frontier Capital Management Co LLC
2.90%2.85M0.66%+656.75K
Emil KakkisFounder, President, CEO & Director
2.80%2.75M0.62%+613.61K
Geode Capital Management, LLC
2.62%2.58M0.74%+729.44K
Bellevue Asset Management AG
2.02%1.98M0.41%-397.23K
D. E. Shaw & Co., L.P.
1.76%1.73M0.48%+469.18K
Sofinnova Investments, Inc.
1.75%1.72M1.46%-1.43M
Adage Capital Management, L.P.
1.61%1.58M1.12%+1.10M
GW&K Investment Management, LLC
1.51%1.48M0.14%-134.25K
MPM BioImpact LLC
1.44%1.42M1.44%+1.42M
T. Rowe Price Group, Inc.
1.38%1.36M0.56%+552.39K
Wellington Management Group LLP
1.27%1.25M1.42%-1.39M
© 2026 Longbridge｜Terms of ServicePrivacy Policy